IDT Australia Ltd logo

IDT Australia Ltd (IDT)

Market Open
15 Dec, 23:04
ASX ASX
A$
0. 10
0
0%
A$
- Market Cap
- P/E Ratio
0.03% Div Yield
171 Volume
-0.02 Eps
A$ 0.1
Previous Close
Day Range
0.1 0.1
Year Range
0.08 0.14
Want to track IDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

IDT Chart

IDT Australia Ltd Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Paul Anthony McDonald CEO
ASX Exchange
AU000000IDT0 ISIN
Australia Country
- Employees
- Last Dividend
16 Apr 2010 Last Split
- IPO Date

Overview

IDT Australia Limited is a multifaceted pharmaceutical company founded in 1975, headquartered in Boronia, Australia. It operates globally, with its market presence spanning Australia, Asia, Europe, and the United States. The company is deeply involved in the pharmaceutical field, focusing on the research, development, manufacture, and sale of both active pharmaceutical ingredients (APIs) and finished dose forms (FDFs). IDT Australia Limited is known for its comprehensive range of services and products, addressing various needs across the pharmaceutical industry spectrum.

Products and Services

  • Microbiological and Analytical Testing - IDT Australia Limited provides thorough testing services, ensuring the safety, efficacy, and quality of pharmaceutical products through microbiological and extensive analytical assessments.
  • Clinical Packaging and Pharmacy Services - They offer bespoke packaging solutions for clinical trials along with a suite of pharmacy services tailored to meet the needs of the healthcare and pharmaceutical sectors.
  • Medicinal Cannabis and Psychedelics - The company is at the forefront of producing medicinal cannabis and psychedelics, adhering to strict quality and regulatory standards, to cater to the growing demand in therapeutic applications.
  • Oral Finished Doses - Specializing in the creation of oral finished doses, IDT Australia Limited manufactures a range of oral pharmaceutical formulations for various therapeutic areas.
  • Aseptic Fill and Finish Solutions - They provide aseptic fill and finish services for both liquid and lyophilised forms, crucial for ensuring the sterility and safety of injectable medicines and other pharmaceutical products.
  • mRNA and ADCs - IDT Australia Limited is involved in the cutting-edge fields of messenger RNA (mRNA) therapies and Antibody-Drug Conjugates (ADCs), highlighting its commitment to innovative pharmaceutical development.
  • Contract Manufacturing Services - The company extends its expertise to offer contract manufacturing services, allowing other pharmaceutical and biotechnological companies to benefit from its experienced manufacturing capabilities.

Contact Information

Address: 45 Wadhurst Drive
Phone: 61 3 9801 8888